Deployment of an 8 Fr Angio-Seal device in the femoral vein was successful in 100% of patients undergoing transcatheter procedures requiring venous access, demonstrating safety and feasibility.
Observational (n=110)
Is the use of an 8 Fr Angio-Seal device safe and feasible for closing the femoral vein puncture site after transcatheter procedures?
The use of an 8 Fr Angio-Seal device is a safe and feasible method for achieving hemostasis in the femoral vein following transcatheter procedures.
The use of anchor-based, collagen-derived vascular sealing devices in femoral vein punctures during right and left heart catheterizations or coronary interventions necessitating venous access for temporary pacemaker or hemodynamic monitoring has not been studied. We hypothesized that using these devices in the femoral vein would be practical and reliable. One hundred and ten consecutive patients undergoing right and left heart catheterization (56 patients, 51%) or coronary intervention (54 patients, 49%) were included in this study. Forty-five of the interventions received IIb/IIIa inhibitors in combination with heparin, enoxaparin, aspirin, and clopidogrel. The Angio-Seal device was successfully deployed in the femoral vein in all patients, whereas 93 (85%) received arterial Angio-Seal, 8 received Perclose, and 9 (8%) had manual pressure or a Fem-Stop applied to control arterial bleeding after deployment. We conclude that in patients undergoing transcatheter procedures requiring venous access, the use of an 8 Fr Angio-Seal to seal the femoral vein is safe and feasible.
Humberto Coto (Thu,) conducted a observational in Patients undergoing right and left heart catheterization or coronary intervention requiring venous access (n=110). Angio-Seal device was evaluated on Successful deployment in the femoral vein. Deployment of an 8 Fr Angio-Seal device in the femoral vein was successful in 100% of patients undergoing transcatheter procedures requiring venous access, demonstrating safety and feasibility.